doi: 10.1002/sim.4780101105.
A general parametric approach to the meta-analysis of randomized clinical trials
Affiliations
- PMID: 1792461
- DOI: 10.1002/sim.4780101105
Item in Clipboard
A general parametric approach to the meta-analysis of randomized clinical trials
Stat Med.
1991 Nov.
Abstract
Meta-analysis provides a systematic and quantitative approach to the summary of results from randomized studies. Whilst many authors have published actual meta-analyses concerning specific therapeutic questions, less has been published about comprehensive methodology. This article presents a general parametric approach, which utilizes efficient score statistics and Fisher's information, and relates this to different methods suggested by previous authors. Normally distributed, binary, ordinal and survival data are considered. Both the fixed effects and random effects model for treatments are described.
Similar articles
-
Statistical methods for the meta-analysis of cluster randomization trials.Stat Methods Med Res. 2001 Oct;10(5):325-38. doi: 10.1177/096228020101000502. Stat Methods Med Res. 2001. PMID: 11697225
-
Combining summaries of binary outcomes with those of continuous outcomes in a meta-analysis.J Biopharm Stat. 1999 Mar;9(1):1-16. doi: 10.1081/BIP-100100997. J Biopharm Stat. 1999. PMID: 10091907
-
A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.Clin Trials. 2017 Apr;14(2):192-200. doi: 10.1177/1740774516683920. Epub 2017 Jan 6. Clin Trials. 2017. PMID: 28059578
-
Meta-analyses involving cluster randomization trials: a review of published literature in health care.Stat Methods Med Res. 2003 Dec;12(6):515-30. doi: 10.1191/0962280203sm347oa. Stat Methods Med Res. 2003. PMID: 14653354 Review.
-
Sensitivity subgroup analysis based on single-center vs. multi-center trial status when interpreting meta-analyses pooled estimates: the logical way forward.J Clin Epidemiol. 2016 Jun;74:80-92. doi: 10.1016/j.jclinepi.2015.08.027. Epub 2015 Nov 17. J Clin Epidemiol. 2016. PMID: 26597972 Review.
Cited by
-
Cellular dormancy in minimal residual disease following targeted therapy.Breast Cancer Res. 2021 Jun 4;23(1):63. doi: 10.1186/s13058-021-01416-9. Breast Cancer Res. 2021. PMID: 34088357 Free PMC article.
-
Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis.Obes Surg. 2013 Mar;23(3):397-407. doi: 10.1007/s11695-012-0852-4. Obes Surg. 2013. PMID: 23315094 Review.
-
Prognostic significance of osteopontin expression in non-small-cell lung cancer: A meta-analysis.Mol Clin Oncol. 2015 May;3(3):633-638. doi: 10.3892/mco.2015.517. Epub 2015 Feb 26. Mol Clin Oncol. 2015. PMID: 26137280 Free PMC article.
-
Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease.J Renin Angiotensin Aldosterone Syst. 2016 Jul 3;17(3):1470320316656481. doi: 10.1177/1470320316656481. Print 2016 Jul. J Renin Angiotensin Aldosterone Syst. 2016. PMID: 27377659 Free PMC article. Review.
-
Renin-angiotensin system blockade for the risk of cancer and death.J Renin Angiotensin Aldosterone Syst. 2016 Jul 8;17(3):1470320316656679. doi: 10.1177/1470320316656679. Print 2016 Jul. J Renin Angiotensin Aldosterone Syst. 2016. PMID: 27402638 Free PMC article. Review.